{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:32:39Z","timestamp":1776511959238,"version":"3.51.2"},"reference-count":128,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Physiol Pathophysiol Pharmacol"],"DOI":"10.62347\/mtwv3745","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T23:32:49Z","timestamp":1730417569000},"page":"96-110","source":"Crossref","is-referenced-by-count":3,"title":["Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer\u2019s disease"],"prefix":"10.62347","volume":"16","author":[{"given":"Moeka","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1326-5-10","article-title":"Antidepressants are a rational complementary therapy for the treatment of Alzheimer’s disease","volume":"5","author":"Aboukhatwa","year":"2010","unstructured":"Aboukhatwa M, Dosanjh L and Luo Y. Antidepressants are a rational complementary therapy for the treatment of Alzheimer’s disease. Mol Neurodegener 2010; 5: 10.","journal-title":"Mol Neurodegener"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11095-017-2329-6","article-title":"Drug discovery, development and delivery in Alzheimer’s disease","volume":"35","author":"Brambilla","year":"2017","unstructured":"Brambilla D. Drug discovery, development and delivery in Alzheimer’s disease. Pharm Res 2017; 35: 3.","journal-title":"Pharm Res"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Vijayraghavan S, Major AJ and Everling S. Muscarinic M1 receptor overstimulation disrupts working memory activity for rules in primate prefrontal cortex. Neuron 2018; 98: 1256-1268, e1254.","DOI":"10.1016\/j.neuron.2018.05.027"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","article-title":"Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE","volume":"22","author":"Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, Tahirovic S, Herms J, Willem M, Pettkus N, Butovsky O, Bartenstein P, Edbauer D, Rominger A, Ertürk A, Grathwohl SA, Neher JJ, Holtzman DM, Meyer-Luehmann M and Haass C. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 2019; 22: 191-204.","journal-title":"Nat Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/1673-5374.264445","article-title":"Selective serotonin reuptake inhibitors and Alzheimer’s disease","volume":"15","author":"Mdawar","year":"2020","unstructured":"Mdawar B, Ghossoub E and Khoury R. Selective serotonin reuptake inhibitors and Alzheimer’s disease. Neural Regen Res 2020; 15: 41-46.","journal-title":"Neural Regen Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8814","DOI":"10.3390\/ijms23158814","article-title":"The implication of 5-HT receptor family members in aggression, depression and suicide: similarity and difference","volume":"23","author":"NK","year":"2022","unstructured":"Popova NK, Tsybko AS and Naumenko VS. The implication of 5-HT receptor family members in aggression, depression and suicide: similarity and difference. Int J Mol Sci 2022; 23: 8814.","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s40501-017-0111-3","article-title":"The role of 5-HT2a\/2c receptors in nociception and opioid antinociception: a review of the preclinical literature","volume":"4","author":"Lippold","year":"2017","unstructured":"Lippold K and Dewey W. The role of 5-HT2a\/2c receptors in nociception and opioid antinociception: a review of the preclinical literature. Curr Treat Options Psychiatry 2017; 4: 210-220.","journal-title":"Curr Treat Options Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","unstructured":"Zhang G and Stackman RW Jr. The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol 2015; 6: 225.","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3389\/fphar.2019.00540","article-title":"The role of N-methyl-D-aspartate receptor neurotransmission and precision medicine in behavioral and psychological symptoms of dementia","volume":"10","author":"Lin","year":"2019","unstructured":"Lin CH and Lane HY. The role of N-methyl-D-aspartate receptor neurotransmission and precision medicine in behavioral and psychological symptoms of dementia. Front Pharmacol 2019; 10: 540.","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"114189","DOI":"10.1016\/j.bbr.2022.114189","article-title":"Sex-dependent worsening of NMDA-induced responses, anxiety, hypercortisolemia, and organometry of early peripheral immunoendocrine impairment in adult 3xTg-AD mice and their long-lasting ontogenic modulation by neonatal handling","volume":"438","author":"Baeta-Corral R","year":"2023","unstructured":"Baeta-Corral R, De la Fuente M and Giménez-Llort L. Sex-dependent worsening of NMDA-induced responses, anxiety, hypercortisolemia, and organometry of early peripheral immunoendocrine impairment in adult 3xTg-AD mice and their long-lasting ontogenic modulation by neonatal handling. Behav Brain Res 2023; 438: 114189.","journal-title":"Behav Brain Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"173827","DOI":"10.1016\/j.pbb.2024.173827","article-title":"Memantine alleviates cognitive impairment and hippocampal morphology injury in a mouse model of chronic alcohol exposure","volume":"20","author":"Gao","year":"2024","unstructured":"Gao DP, Weng QY, Zhang YY, Ou YX, Niu YF, Lou Q, Xie DL, Cai Y and Yang JH. Memantine alleviates cognitive impairment and hippocampal morphology injury in a mouse model of chronic alcohol exposure. Pharmacol Biochem Behav 2024; 20: 173827.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13195-024-01516-6","article-title":"The criteria used to rule out mild cognitive impairment impact dementia incidence rates in subjective cognitive decline","volume":"16","author":"Whitfield","year":"2024","unstructured":"Whitfield T, Chouliaras L, Morrell R, Rubio D, Radford D, Marchant NL and Walker Z. The criteria used to rule out mild cognitive impairment impact dementia incidence rates in subjective cognitive decline. Alzheimers Res Ther 2024; 16: 142.","journal-title":"Alzheimers Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the lancet commission","volume":"396","author":"Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L and Mukadam N. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet 2020; 396: 413-446.","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","unstructured":"Self WK and Holtzman DM. Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med 2023; 29: 2187-2199.","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2374608","DOI":"10.1080\/19490976.2024.2374608","article-title":"Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3\/IKK\/NF-kappaB signaling via gut microbial tryptophan metabolites","volume":"16","author":"Li","year":"2024","unstructured":"Li S, Cai Y, Guan T, Zhang Y, Huang K, Zhang Z, Cao W and Guan X. Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3\/IKK\/NF-kappaB signaling via gut microbial tryptophan metabolites. Gut Microbes 2024; 16: 2374608.","journal-title":"Gut Microbes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"133570","DOI":"10.1016\/j.jhazmat.2024.133570","article-title":"Inhalation of diesel exhaust particulate matter accelerates weight gain via regulation of hypothalamic appetite-related genes and gut microbiota metabolism","volume":"466","author":"Liu","year":"2024","unstructured":"Liu H, Wang G, Zhang J, Lu B, Li D and Chen J. Inhalation of diesel exhaust particulate matter accelerates weight gain via regulation of hypothalamic appetite-related genes and gut microbiota metabolism. J Hazard Mater 2024; 466: 133570.","journal-title":"J Hazard Mater"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/biom12020196","article-title":"DOTA: deep learning optimal transport approach to advance drug repositioning for Alzheimer’s disease","volume":"12","author":"Chyr","year":"2022","unstructured":"Chyr J, Gong H and Zhou X. DOTA: deep learning optimal transport approach to advance drug repositioning for Alzheimer’s disease. Biomolecules 2022; 12: 196.","journal-title":"Biomolecules"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"114491","DOI":"10.1016\/j.bbr.2023.114491","article-title":"Nasal administration of orexin A partially rescues dizocilpine-induced cognitive impairments in female C57BL\/6 J mice","volume":"450","author":"Durairaja","year":"2023","unstructured":"Durairaja A, Pandey S, Kahl E and Fendt M. Nasal administration of orexin A partially rescues dizocilpine-induced cognitive impairments in female C57BL\/6 J mice. Behav Brain Res 2023; 450: 114491.","journal-title":"Behav Brain Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1113\/jphysiol.2014.272757","article-title":"Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors","volume":"592","author":"Perin","year":"2014","unstructured":"Perin M, Longordo F, Massonnet C, Welker E and Lüthi A. Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors. J Physiol 2014; 592: 4277-4295.","journal-title":"J Physiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.3390\/ijms24097821","article-title":"The role of supplements and over-the-counter products to improve sleep in children: a systematic review","volume":"24","author":"Innocenti","year":"2023","unstructured":"Innocenti A, Lentini G, Rapacchietta S, Cinnirella P, Elia M, Ferri R and Bruni O. The role of supplements and over-the-counter products to improve sleep in children: a systematic review. Int J Mol Sci 2023; 24: 7821.","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Miyamoto K, Sujino T and Kanai T. The tryptophan metabolic pathway of the microbiome and host cells in health and disease. Int Immunol 2024: dxae035.","DOI":"10.1093\/intimm\/dxae035"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"120819","DOI":"10.1016\/j.jns.2023.120819","article-title":"The role of the kynurenine pathway in cognitive functioning after stroke: a prospective clinical study","volume":"454","author":"Bakker","year":"2023","unstructured":"Bakker L, Ramakers IHGB, J P M Eussen S, Choe K, van den Hove DLA, Kenis G, Rutten BPF, van Oostenbrugge RJ, Staals J, Ulvik A, Ueland PM, Verhey FRJ and Köhler S. The role of the kynurenine pathway in cognitive functioning after stroke: a prospective clinical study. J Neurol Sci 2023; 454: 120819.","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3389\/fimmu.2019.02113","article-title":"Tryptophan dietary impacts gut barrier and metabolic diseases","volume":"10","author":"Taleb","year":"2019","unstructured":"Taleb S. Tryptophan dietary impacts gut barrier and metabolic diseases. Front Immunol 2019; 10: 2113.","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","unstructured":"Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C and Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191-1193.","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/jcag\/gwad020","article-title":"Emerging roles of gut serotonin in regulation of immune response, microbiota composition and intestinal inflammation","volume":"7","author":"Grondin","year":"2023","unstructured":"Grondin JA and Khan WI. Emerging roles of gut serotonin in regulation of immune response, microbiota composition and intestinal inflammation. J Can Assoc Gastroenterol 2023; 7: 88-96.","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2249.2010.04150.x","article-title":"Gut hormones: emerging role in immune activation and inflammation","volume":"161","author":"Khan","year":"2010","unstructured":"Khan WI and Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 2010; 161: 19-27.","journal-title":"Clin Exp Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","article-title":"The interplay between the intestinal microbiota and the brain","volume":"10","author":"SM","year":"2012","unstructured":"Collins SM, Surette M and Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-742.","journal-title":"Nat Rev Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Haq S, Wang H, Grondin J, Banskota S, Marshall JK, Khan II, Chauhan U, Cote F, Kwon YH, Philpott D, Brumell JH, Surette M, Steinberg GR and Khan WI. Disruption of autophagy by increased 5-HT alters gut microbiota and enhances susceptibility to experimental colitis and Crohn’s disease. Sci Adv 2021; 7: eabi6442.","DOI":"10.1126\/sciadv.abi6442"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Wright SC, Avet C, Gaitonde SA, Muneta-Arrate I, Le Gouill C, Hogue M, Breton B, Koutsilieri S, Diez-Alarcia R, Héroux M, Lauschke VM and Bouvier M. Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling. Sci Signal 2024; 17: eadi4747.","DOI":"10.1126\/scisignal.adi4747"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4331\/wjbc.v12.i6.104","article-title":"Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease","volume":"12","author":"Ikeda","year":"2021","unstructured":"Ikeda Y, Nagase N, Tsuji A, Kitagishi Y and Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12: 104-113.","journal-title":"World J Biol Chem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/biomedicines12061158","article-title":"Comparison of protective effects of antidepressants mediated by serotonin receptor in abeta-oligomer-induced neurotoxicity","volume":"12","author":"Yamamoto","year":"2024","unstructured":"Yamamoto K, Tsuji M, Oguchi T, Momma Y, Ohashi H, Ito N, Nohara T, Nakanishi T, Ishida A, Hosonuma M, Nishikawa T, Murakami H and Kiuchi Y. Comparison of protective effects of antidepressants mediated by serotonin receptor in abeta-oligomer-induced neurotoxicity. Biomedicines 2024; 12: 1158.","journal-title":"Biomedicines"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Verdurand M and Zimmer L. Hippocampal 5-HT1A receptor expression changes in prodromal stages of Alzheimer’s disease: beneficial or deleterious? Neuropharmacology 2017; 123: 446-454.","DOI":"10.1016\/j.neuropharm.2017.06.021"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Anzalone M, Karam SA, Briting SRR, Petersen S, Thomsen MB, Babcock AA, Landau AM, Finsen B and Metaxas A. Serotonin-2B receptor (5-HT(2B)R) expression and binding in the brain of APP(swe)\/PS1(dE9) transgenic mice and in Alzheimer’s disease brain tissue. Neurosci Lett 2024; 17: 138013.","DOI":"10.1101\/2024.05.30.596651"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3233\/JAD-240063","article-title":"The 5HT2b receptor in Alzheimer’s disease: increased levels in patient brains and antagonist attenuation of amyloid and tau induced dysfunction","volume":"98","author":"Acquarone","year":"2024","unstructured":"Acquarone E, Argyrousi EK, Arancio O, Watterson DM and Roy SM. The 5HT2b receptor in Alzheimer’s disease: increased levels in patient brains and antagonist attenuation of amyloid and tau induced dysfunction. J Alzheimers Dis 2024; 98: 1349-1360.","journal-title":"J Alzheimers Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2004.07.093","article-title":"Regulation of cAMP levels in area CA1 of hippocampus by Gi\/o-coupled receptors is stimulus dependent in mice","volume":"370","author":"AM","year":"2004","unstructured":"Vanhoose AM, Ritchie MD and Winder DG. Regulation of cAMP levels in area CA1 of hippocampus by Gi\/o-coupled receptors is stimulus dependent in mice. Neurosci Lett 2004; 370: 80-83.","journal-title":"Neurosci Lett"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1517\/13543784.10.4.633","article-title":"Kynurenic acid antagonists and kynurenine pathway inhibitors","volume":"10","author":"Stone","year":"2001","unstructured":"Stone TW. Kynurenic acid antagonists and kynurenine pathway inhibitors. Expert Opin Investig Drugs 2001; 10: 633-645.","journal-title":"Expert Opin Investig Drugs"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.biopsych.2021.05.021","article-title":"The kynurenine pathway in traumatic brain injury: implications for psychiatric outcomes","volume":"91","author":"Meier","year":"2022","unstructured":"Meier TB and Savitz J. The kynurenine pathway in traumatic brain injury: implications for psychiatric outcomes. Biol Psychiatry 2022; 91: 449-458.","journal-title":"Biol Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Stone TW and Williams RO. Tryptophan metabolism as a ‘reflex’ feature of neuroimmune communication: sensor and effector functions for the indoleamine-2, 3-dioxygenase kynurenine pathway. J Neurochem 2024; 168: 3333-3357.","DOI":"10.1111\/jnc.16015"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Ostapiuk A and Urbanska EM. Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? CNS Neurosci Ther 2022; 28: 19-35.","DOI":"10.1111\/cns.13768"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3390\/ijms21072431","article-title":"Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines","volume":"21","author":"Tanaka","year":"2020","unstructured":"Tanaka M, Toldi J and Vécsei L. Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines. Int J Mol Sci 2020; 21: 2431.","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data","volume":"38","author":"CG","year":"1999","unstructured":"Parsons CG, Danysz W and Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data. Neuropharmacol 1999; 38: 735-767.","journal-title":"Neuropharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","article-title":"Dysfunction of NMDA receptors in Alzheimer’s disease","volume":"37","author":"Zhang","year":"2016","unstructured":"Zhang Y, Li P, Feng J and Wu M. Dysfunction of NMDA receptors in Alzheimer’s disease. Neurol Sci 2016; 37: 1039-1047.","journal-title":"Neurol Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/bja\/aer368","article-title":"Roles of neuronal nitric oxide synthase, oxidative stress, and propofol in N-methyl-D-aspartate-induced dilatation of cerebral arterioles","volume":"108","author":"Hama-Tomioka","year":"2012","unstructured":"Hama-Tomioka K, Kinoshita H, Nakahata K, Kondo T, Azma T, Kawahito S, Hatakeyama N and Matsuda N. Roles of neuronal nitric oxide synthase, oxidative stress, and propofol in N-methyl-D-aspartate-induced dilatation of cerebral arterioles. Br J Anaesth 2012; 108: 21-29.","journal-title":"Br J Anaesth"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"100993","DOI":"10.1016\/j.jbc.2021.100993","article-title":"Delivering progranulin to neuronal lysosomes protects against excitotoxicity","volume":"297","author":"Davis","year":"2021","unstructured":"Davis SE, Roth JR, Aljabi Q, Hakim AR, Savell KE, Day JJ and Arrant AE. Delivering progranulin to neuronal lysosomes protects against excitotoxicity. J Biol Chem 2021; 297: 100993.","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2015.00473","article-title":"NMDA receptor function during senescence: Implication on cognitive performance","volume":"9","author":"Kumar","year":"2015","unstructured":"Kumar A. NMDA receptor function during senescence: Implication on cognitive performance. Front Neurosci 2015; 9: 1-15.","journal-title":"Front Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Abraham WC, Jones OD and Glanzman DL. Is plasticity of synapses the mechanism of long-term memory storage? NPJ Sci Learn 2019; 4: 9.","DOI":"10.1038\/s41539-019-0048-y"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"DH","year":"2001","unstructured":"Mauch DH, Nägler K, Schumacher S, Göritz C, Müller EC, Otto A and Pfrieger FW. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354-1357.","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.7150\/ijbs.63512","article-title":"Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling","volume":"17","author":"Liu","year":"2021","unstructured":"Liu T, Li Y, Yang B, Wang H, Lu C, Chang AK, Huang X, Zhang X, Lu Z, Lu X and Gao B. Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling. Int J Biol Sci 2021; 17: 3702-3716.","journal-title":"Int J Biol Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1471-4159.2007.05005.x","article-title":"Polarization of caveolins and caveolae during migration of immortalized neurons","volume":"104","author":"Lentini","year":"2008","unstructured":"Lentini D, Guzzi F, Pimpinelli F, Zaninetti R, Cassetti A, Coco S, Maggi R and Parenti M. Polarization of caveolins and caveolae during migration of immortalized neurons. J Neurochem 2008; 104: 514-523.","journal-title":"J Neurochem"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/bs.ctm.2020.08.007","article-title":"Roles of microglial membranes in Alzheimer’s disease","volume":"86","author":"Shin","year":"2020","unstructured":"Shin JW and Lee JC. Roles of microglial membranes in Alzheimer’s disease. Curr Top Membr 2020; 86: 301-314.","journal-title":"Curr Top Membr"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/glia.24478","article-title":"Remyelinating effect driven by transferrin-loaded extracellular vesicles","volume":"72","author":"Mattera","year":"2024","unstructured":"Mattera V, Occhiuzzi F, Correale J and Pasquini JM. Remyelinating effect driven by transferrin-loaded extracellular vesicles. Glia 2024; 72: 338-361.","journal-title":"Glia"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","article-title":"Role of caveolae and caveolins in health and disease","volume":"84","author":"Cohen","year":"2004","unstructured":"Cohen AW, Hnasko R, Schubert W and Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84: 1341-1379.","journal-title":"Physiol Rev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","unstructured":"Parton RG and Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007; 8: 185-194.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"33310","DOI":"10.1074\/jbc.M111.255976","article-title":"Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons","volume":"286","author":"Head","year":"2011","unstructured":"Head BP, Hu Y, Finley JC, Saldana MD, Bonds JA, Miyanohara A, Niesman IR, Ali SS, Murray F, Insel PA, Roth DM, Patel HH and Patel PM. Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons. J Biol Chem 2011; 286: 33310-33321.","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.biopsych.2015.09.020","article-title":"Neuron-targeted caveolin-1 improves molecular signaling, plasticity, and behavior dependent on the hippocampus in adult and aged mice","volume":"81","author":"Mandyam","year":"2017","unstructured":"Mandyam CD, Schilling JM, Cui W, Egawa J, Niesman IR, Kellerhals SE, Staples MC, Busija AR, Risbrough VB, Posadas E, Grogman GC, Chang JW, Roth DM, Patel PM, Patel HH and Head BP. Neuron-targeted caveolin-1 improves molecular signaling, plasticity, and behavior dependent on the hippocampus in adult and aged mice. Biol Psychiatry 2017; 81: 101-110.","journal-title":"Biol Psychiatry"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1523\/JNEUROSCI.5824-08.2009","article-title":"Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar\/lipid raft pathway","volume":"29","author":"Francesconi","year":"2009","unstructured":"Francesconi A, Kumari R and Zukin RS. Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar\/lipid raft pathway. J Neurosci 2009; 29: 3590-3602.","journal-title":"J Neurosci"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.24358","article-title":"Increased coupling of caveolin-1 and estrogen receptor alpha contributes to the fragile X syndrome","volume":"77","author":"Yang","year":"2015","unstructured":"Yang Q, Yang L, Zhang K, Guo YY, Liu SB, Wu YM, Li XQ, Song Q, Zhuo M and Zhao MG. Increased coupling of caveolin-1 and estrogen receptor alpha contributes to the fragile X syndrome. Ann Neurol 2015; 77: 618-636.","journal-title":"Ann Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1007\/s12035-023-03269-z","article-title":"Caveolin-1-mediated cholesterol accumulation contributes to exaggerated mGluR-dependent long-term depression and impaired cognition in Fmr1 knockout mice","volume":"60","author":"Luo","year":"2023","unstructured":"Luo L, Yang L, Zhang K, Zhou SM, Wang Y, Yang LK, Feng B, Liu SB, Wu YM, Zhao MG and Yang Q. Caveolin-1-mediated cholesterol accumulation contributes to exaggerated mGluR-dependent long-term depression and impaired cognition in Fmr1 knockout mice. Mol Neurobiol 2023; 60: 3379-3395.","journal-title":"Mol Neurobiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1074\/jbc.M304777200","article-title":"The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity","volume":"279","author":"Gaudreault","year":"2004","unstructured":"Gaudreault SB, Chabot C, Gratton JP and Poirier J. The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity. J Biol Chem 2004; 279: 356-362.","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"104837","DOI":"10.1016\/j.jbc.2023.104837","article-title":"A vital role for PICK1 in the differential regulation of metabotropic glutamate receptor internalization and synaptic AMPA receptor endocytosis","volume":"299","author":"Ramsakha","year":"2023","unstructured":"Ramsakha N, Ojha P, Pal S, Routh S, Citri A and Bhattacharyya S. A vital role for PICK1 in the differential regulation of metabotropic glutamate receptor internalization and synaptic AMPA receptor endocytosis. J Biol Chem 2023; 299: 104837.","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/gb-2004-5-3-214","article-title":"The caveolin proteins","volume":"5","author":"Williams","year":"2004","unstructured":"Williams TM and Lisanti MP. The caveolin proteins. Genome Biol 2004; 5: 214.","journal-title":"Genome Biol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cell.2007.11.042","article-title":"PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function","volume":"132","author":"Hill","year":"2008","unstructured":"Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF and Parton RG. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008; 132: 113-124.","journal-title":"Cell"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.1074\/jbc.274.13.8858","article-title":"Regulation of G protein-coupled receptor kinases by caveolin","volume":"274","author":"CV","year":"1999","unstructured":"Carman CV, Lisanti MP and Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 1999; 274: 8858-8864.","journal-title":"J Biol Chem"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fphys.2017.00295","article-title":"Caveolin-1: functional insights into its role in muscarine- and serotonin-induced smooth muscle constriction in murine airways","volume":"8","author":"Keshavarz","year":"2017","unstructured":"Keshavarz M, Schwarz H, Hartmann P, Wiegand S, Skill M, Althaus M, Kummer W and Krasteva-Christ G. Caveolin-1: functional insights into its role in muscarine- and serotonin-induced smooth muscle constriction in murine airways. Front Physiol 2017; 8: 295.","journal-title":"Front Physiol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12551-020-00772-8","article-title":"Structure, dynamics and lipid interactions of serotonin receptors: excitements and challenges","volume":"13","author":"Sarkar","year":"2020","unstructured":"Sarkar P, Mozumder S, Bej A, Mukherjee S, Sengupta J and Chattopadhyay A. Structure, dynamics and lipid interactions of serotonin receptors: excitements and challenges. Biophys Rev 2020; 13: 101-122.","journal-title":"Biophys Rev"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neubiorev.2021.06.044","article-title":"Caveolin-1, a novel player in cognitive decline","volume":"129","author":"Tang","year":"2021","unstructured":"Tang W, Li Y, Li Y and Wang Q. Caveolin-1, a novel player in cognitive decline. Neurosci Biobehav Rev 2021; 129: 95-106.","journal-title":"Neurosci Biobehav Rev"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"40843","DOI":"10.18632\/oncotarget.17257","article-title":"High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: a potential molecular mechanism for diabetes-induced cognitive dysfunction","volume":"8","author":"Wu","year":"2017","unstructured":"Wu J, Zhou SL, Pi LH, Shi XJ, Ma LR, Chen Z, Qu ML, Li X, Nie SD, Liao DF, Pei JJ and Wang S. High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: a potential molecular mechanism for diabetes-induced cognitive dysfunction. Oncotarget 2017; 8: 40843-40856.","journal-title":"Oncotarget"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/ijp.IJP_81_17","article-title":"Alteration in memory cognition due to activation of caveolin-1 and oxidative damage in a model of dementia of Alzheimer’s type","volume":"51","author":"Gupta","year":"2019","unstructured":"Gupta A, Sharma A, Kumar A and Goyal R. Alteration in memory cognition due to activation of caveolin-1 and oxidative damage in a model of dementia of Alzheimer’s type. Indian J Pharmacol 2019; 51: 173-180.","journal-title":"Indian J Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"10485","DOI":"10.1074\/jbc.273.17.10485","article-title":"Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein","volume":"273","author":"Ikezu","year":"1998","unstructured":"Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP and Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J Biol Chem 1998; 273: 10485-10495.","journal-title":"J Biol Chem"},{"key":"ref69","unstructured":"Sharma S, Singh M and Sharma PL. Ameliorative effect of daidzein: a caveolin-1 inhibitor in vascular endothelium dysfunction induced by ovariectomy. Indian J Exp Biol 2012; 50: 28-34."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2261-11-43","article-title":"Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart","volume":"11","author":"Ajmani","year":"2011","unstructured":"Ajmani P, Yadav HN, Singh M and Sharma PL. Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord 2011; 11: 43.","journal-title":"BMC Cardiovasc Disord"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/ars.2021.0233","article-title":"Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis","volume":"37","author":"Tang","year":"2022","unstructured":"Tang W, Li Y, He S, Jiang T, Wang N, Du M, Cheng B, Gao W, Li Y and Wang Q. Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis. Antioxid Redox Signal 2022; 37: 867-886.","journal-title":"Antioxid Redox Signal"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.freeradbiomed.2021.04.025","article-title":"mTOR in Alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder","volume":"169","author":"Perluigi","year":"2021","unstructured":"Perluigi M, Di Domenico F, Barone E and Butterfield DA. mTOR in Alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med 2021; 169: 382-396.","journal-title":"Free Radic Biol Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"166844","DOI":"10.1016\/j.bbadis.2023.166844","article-title":"Orexin-A\/OX1R is involved in regulation of autophagy to promote cortisol secretion in adrenocortical cell","volume":"1870","author":"Guo","year":"2024","unstructured":"Guo X, Wen J, Gao Q, Zhao Y, Zhao Y, Wang C, Xu N, Shao Y and Chang X. Orexin-A\/OX1R is involved in regulation of autophagy to promote cortisol secretion in adrenocortical cell. Biochim Biophys Acta Mol Basis Dis 2024; 1870: 166844.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1007\/s11033-023-08459-5","article-title":"Orexin pathway in Parkinson’s disease: a review","volume":"50","author":"Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Zaafar D and Batiha GE. Orexin pathway in Parkinson’s disease: a review. Mol Biol Rep 2023; 50: 6107-6120.","journal-title":"Mol Biol Rep"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1016\/j.cellsig.2020.109839","article-title":"Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK\/ERK\/mTOR pathway","volume":"79","author":"Xu","year":"2021","unstructured":"Xu D, Kong T, Zhang S, Cheng B, Chen J and Wang C. Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK\/ERK\/mTOR pathway. Cell Signal 2021; 79: 109839.","journal-title":"Cell Signal"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.4161\/auto.7.11.17339","article-title":"Autophagy and p62 in cardiac protein quality control","volume":"7","author":"Su","year":"2011","unstructured":"Su H and Wang X. Autophagy and p62 in cardiac protein quality control. Autophagy 2011; 7: 1382-1383.","journal-title":"Autophagy"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","article-title":"Mitophagy in Alzheimer’s disease: molecular defects and therapeutic approaches","volume":"28","author":"Mary","year":"2023","unstructured":"Mary A, Eysert F, Checler F and Chami M. Mitophagy in Alzheimer’s disease: molecular defects and therapeutic approaches. Mol Psychiatry 2023; 28: 202-216.","journal-title":"Mol Psychiatry"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1038\/s41467-024-49589-z","article-title":"Protein restriction slows the development and progression of pathology in a mouse model of Alzheimer’s disease","volume":"15","author":"Babygirija","year":"2024","unstructured":"Babygirija R, Sonsalla MM, Mill J, James I, Han JH, Green CL, Calubag MF, Wade G, Tobon A, Michael J, Trautman MM, Matoska R, Yeh CY, Grunow I, Pak HH, Rigby MJ, Baldwin DA, Niemi NM, Denu JM, Puglielli L, Simcox J and Lamming DW. Protein restriction slows the development and progression of pathology in a mouse model of Alzheimer’s disease. Nat Commun 2024; 15: 5217.","journal-title":"Nat Commun"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4103\/1673-5374.360164","article-title":"Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review","volume":"18","author":"Yap","year":"2023","unstructured":"Yap KH, Azmin S, Makpol S, Damanhuri HA, Mustapha M, Hamzah JC and Ibrahim NM. Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review. Neural Regen Res 2023; 18: 1179-1185.","journal-title":"Neural Regen Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/15548627.2018.1535292","article-title":"Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration","volume":"15","author":"Rusmini","year":"2019","unstructured":"Rusmini P, Cortese K, Crippa V, Cristofani R, Cicardi ME, Ferrari V, Vezzoli G, Tedesco B, Meroni M, Messi E, Piccolella M, Galbiati M, Garrè M, Morelli E, Vaccari T and Poletti A. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy 2019; 15: 631-651.","journal-title":"Autophagy"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Khalifeh M, Read MI, Barreto GE and Sahebkar A. Trehalose against Alzheimer’s disease: insights into a potential therapy. Bioessays 2020; 42: e1900195.","DOI":"10.1002\/bies.201900195"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nbd.2005.02.003","article-title":"Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42","volume":"20","author":"Liu","year":"2005","unstructured":"Liu R, Barkhordarian H, Emadi S, Park CB and Sierks MR. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42. Neurobiol Dis 2005; 20: 74-81.","journal-title":"Neurobiol Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"10528","DOI":"10.1074\/jbc.M116.719286","article-title":"Trehalose alters subcellular trafficking and the metabolism of the alzheimer-associated amyloid precursor protein","volume":"291","author":"Tien","year":"2016","unstructured":"Tien NT, Karaca I, Tamboli IY and Walter J. Trehalose alters subcellular trafficking and the metabolism of the alzheimer-associated amyloid precursor protein. J Biol Chem 2016; 291: 10528-10540.","journal-title":"J Biol Chem"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"173406","DOI":"10.1016\/j.pbb.2022.173406","article-title":"Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer’s disease-like pathology in a mouse model","volume":"217","author":"Pupyshev","year":"2022","unstructured":"Pupyshev AB, Belichenko VM, Tenditnik MV, Bashirzade AA, Dubrovina NI, Ovsyukova MV, Akopyan AA, Fedoseeva LA, Korolenko TA, Amstislavskaya TG and Tikhonova MA. Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer’s disease-like pathology in a mouse model. Pharmacol Biochem Behav 2022; 217: 173406.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/pharmaceutics16060813","article-title":"Alimentary treatment with trehalose in a pharmacological model of Alzheimer’s disease in mice: effects of different dosages and treatment regimens","volume":"16","author":"Pupyshev","year":"2024","unstructured":"Pupyshev AB, Akopyan AA, Tenditnik MV, Ovsyukova MV, Dubrovina NI, Belichenko VM, Korolenko TA, Zozulya SA, Klyushnik TP and Tikhonova MA. Alimentary treatment with trehalose in a pharmacological model of Alzheimer’s disease in mice: effects of different dosages and treatment regimens. Pharmaceutics 2024; 16: 813.","journal-title":"Pharmaceutics"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"43466","DOI":"10.1038\/srep43466","article-title":"Enhancing lysosomal biogenesis and autophagic flux by activating the transcription factor EB protects against cadmium-induced neurotoxicity","volume":"7","author":"Pi","year":"2017","unstructured":"Pi H, Li M, Tian L, Yang Z, Yu Z and Zhou Z. Enhancing lysosomal biogenesis and autophagic flux by activating the transcription factor EB protects against cadmium-induced neurotoxicity. Sci Rep 2017; 7: 43466.","journal-title":"Sci Rep"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","article-title":"Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration","volume":"16","author":"Querfurth","year":"2021","unstructured":"Querfurth H and Lee HK. Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener 2021; 16: 44.","journal-title":"Mol Neurodegener"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Złotek M, Kurowska A, Herbet M and Piątkowska-Chmiel I. GLP-1 analogs, SGLT-2, and DPP-4 inhibitors: a triad of Hope for Alzheimer’s disease therapy. Biomedicine 2023; 11: 3035.","DOI":"10.3390\/biomedicines11113035"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Xia W, Yu H and Wen P. Meta-analysis on GLP-1 mediated modulation of autophagy in islet beta-cells: prospectus for improved wound healing in type 2 diabetes. Int Wound J 2024; 21: e14841.","DOI":"10.1111\/iwj.14841"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ and Sabatini BL. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27: 2866-2875.","journal-title":"J Neurosci"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nn1664","article-title":"Protein kinase A regulates calcium permeability of NMDA receptors","volume":"9","author":"Skeberdis","year":"2006","unstructured":"Skeberdis VA, Chevaleyre V, Lau CG, Goldberg JH, Pettit DL, Suadicani SO, Lin Y, Bennett MV, Yuste R, Castillo PE and Zukin RS. Protein kinase A regulates calcium permeability of NMDA receptors. Nat Neurosci 2006; 9: 501-510.","journal-title":"Nat Neurosci"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1080\/21655979.2022.2026553","article-title":"Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection","volume":"13","author":"Wang","year":"2022","unstructured":"Wang Y, Jiang B and Luo W. Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection. Bioengineered 2022; 13: 6688-6697.","journal-title":"Bioengineered"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4196\/kjpp.2023.27.5.449","article-title":"N-retinylidene-N-retinylethanolamine degradation in human retinal pigment epithelial cells via memantine- and ifenprodil-mediated autophagy","volume":"27","author":"Lee","year":"2023","unstructured":"Lee JR and Jeong KW. N-retinylidene-N-retinylethanolamine degradation in human retinal pigment epithelial cells via memantine- and ifenprodil-mediated autophagy. Korean J Physiol Pharmacol 2023; 27: 449-456.","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","unstructured":"Johnson JW and Kotermanski SE. Mechanism of action of memantine. Curr Opin Pharmacol 2006; 6: 61-67.","journal-title":"Curr Opin Pharmacol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuint.2017.01.010","article-title":"MDMA-induced neurotoxicity of serotonin neurons involves autophagy and rilmenidine is protective against its pathobiology","volume":"105","author":"Mercer","year":"2017","unstructured":"Mercer LD, Higgins GC, Lau CL, Lawrence AJ and Beart PM. MDMA-induced neurotoxicity of serotonin neurons involves autophagy and rilmenidine is protective against its pathobiology. Neurochem Int 2017; 105: 80-90.","journal-title":"Neurochem Int"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Janusz-Kaminska A, Brzozowska A, Tempes A, Urbanska M, Blazejczyk M, Miłek J, Kuzniewska B, Zeng J, Wesławski J, Kisielewska K, Bassell GJ and Jaworski J. Rab11 regulates autophagy at dendritic spines in an mTOR- and NMDA-dependent manner. Mol Biol Cell 2024; 35: ar43.","DOI":"10.1091\/mbc.E23-02-0060"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.14336\/AD.2024.0134","article-title":"Tryptophan metabolism in Alzheimer’s disease with the involvement of microglia and astrocyte crosstalk and gut-brain axis","volume":"15","author":"Xie","year":"2024","unstructured":"Xie L, Wu Q, Li K, Khan MAS, Zhang A, Sinha B, Li S, Chang SL, Brody DL, Grinstaff MW, Zhou S, Alterovitz G, Liu P and Wang X. Tryptophan metabolism in Alzheimer’s disease with the involvement of microglia and astrocyte crosstalk and gut-brain axis. Aging Dis 2024; 15: 2168-2190.","journal-title":"Aging Dis"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/biomedicines12051003","article-title":"A novel RP-UHPLC-MS\/MS approach for the determination of tryptophan metabolites derivatized with 2-bromo-4’-nitroacetophenone","volume":"12","author":"Jankech","year":"2024","unstructured":"Jankech T, Gerhardtova I, Majerova P, Piestansky J, Fialova L, Jampilek J and Kovac A. A novel RP-UHPLC-MS\/MS approach for the determination of tryptophan metabolites derivatized with 2-bromo-4’-nitroacetophenone. Biomedicines 2024; 12: 1003.","journal-title":"Biomedicines"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.3390\/ijms16059772","article-title":"Changing the face of kynurenines and neurotoxicity: therapeutic considerations","volume":"16","author":"Boh&#xE1","year":"2015","unstructured":"Bohár Z, Toldi J, Fülöp F and Vécsei L. Changing the face of kynurenines and neurotoxicity: therapeutic considerations. Int J Mol Sci 2015; 16: 9772-9793.","journal-title":"Int J Mol Sci"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1874104501004010010","article-title":"Glycine transport inhibitors for the treatment of schizophrenia","volume":"4","author":"Hashimoto","year":"2010","unstructured":"Hashimoto K. Glycine transport inhibitors for the treatment of schizophrenia. Open Med Chem J 2010; 4: 10-19.","journal-title":"Open Med Chem J"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1134\/S0006297924060063","article-title":"Astrocytic NMDA receptors","volume":"89","author":"AM","year":"2024","unstructured":"Kosenkov AM, Maiorov SA and Gaidin SG. Astrocytic NMDA receptors. Biochemistry (Mosc) 2024; 89: 1045-1060.","journal-title":"Biochemistry (Mosc)"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s42003-024-06540-8","article-title":"Astrocytes enhance plasticity response during reversal learning","volume":"7","author":"Squadrani","year":"2024","unstructured":"Squadrani L, Wert-Carvajal C, Müller-Komorowska D, Bohmbach K, Henneberger C, Verzelli P and Tchumatchenko T. Astrocytes enhance plasticity response during reversal learning. Commun Biol 2024; 7: 852.","journal-title":"Commun Biol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/diseases10010009","article-title":"D-amino acids as a biomarker in schizophrenia","volume":"10","author":"Taniguchi","year":"2022","unstructured":"Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Kitagishi Y and Matsuda S. D-amino acids as a biomarker in schizophrenia. Diseases 2022; 10: 9.","journal-title":"Diseases"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s12035-017-0550-2","article-title":"Activation of glucagon-like peptide-1 receptor promotes neuroprotection in experimental autoimmune encephalomyelitis by reducing neuroinflammatory responses","volume":"55","author":"Lee","year":"2018","unstructured":"Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH and Choi JW. Activation of glucagon-like peptide-1 receptor promotes neuroprotection in experimental autoimmune encephalomyelitis by reducing neuroinflammatory responses. Mol Neurobiol 2018; 55: 3007-3020.","journal-title":"Mol Neurobiol"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Wu H, Wei J, Zhao X, Liu Y, Chen Z, Wei K, Lu J, Chen W, Jiang M, Li S and Chen T. Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson’s disease in mice by delivering GLP-1 and modulating gut microbiota. Bioeng Transl Med 2022; 8: e10351.","DOI":"10.1002\/btm2.10351"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1080\/1028415X.2021.1880312","article-title":"The effects of polyphenols-rich tropical fruit juice on cognitive function and metabolomics profile - a randomized controlled trial in middle-aged women","volume":"25","author":"Rosli","year":"2022","unstructured":"Rosli H, Shahar S, Rajab NF, Che Din N and Haron H. The effects of polyphenols-rich tropical fruit juice on cognitive function and metabolomics profile - a randomized controlled trial in middle-aged women. Nutr Neurosci 2022; 25: 1577-1593.","journal-title":"Nutr Neurosci"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.09.020","article-title":"System-wide benefits of intermeal fasting by autophagy","volume":"26","author":"Martinez-Lopez","year":"2017","unstructured":"Martinez-Lopez N, Tarabra E, Toledo M, Garcia-Macia M, Sahu S, Coletto L, Batista-Gonzalez A, Barzilai N, Pessin JE, Schwartz GJ, Kersten S and Singh R. System-wide benefits of intermeal fasting by autophagy. Cell Metab 2017; 26: 856-871.","journal-title":"Cell Metab"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-024-00406-z","article-title":"Dietary fasting and time-restricted eating in Huntington’s disease: therapeutic potential and underlying mechanisms","volume":"13","author":"Wells","year":"2024","unstructured":"Wells RG, Neilson LE, McHill AW and Hiller AL. Dietary fasting and time-restricted eating in Huntington’s disease: therapeutic potential and underlying mechanisms. Transl Neurodegener 2024; 13: 17.","journal-title":"Transl Neurodegener"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5582\/bst.2023.01221","article-title":"A circadian rhythm-restricted diet regulates autophagy to improve cognitive function and prolong lifespan","volume":"17","author":"Hu","year":"2023","unstructured":"Hu X, Peng J, Tang W, Xia Y and Song P. A circadian rhythm-restricted diet regulates autophagy to improve cognitive function and prolong lifespan. Biosci Trends 2023; 17: 356-368.","journal-title":"Biosci Trends"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1399121","DOI":"10.3389\/fphar.2024.1399121","article-title":"Alzheimer’s disease and its treatment-yesterday, today, and tomorrow","volume":"15","author":"Kim","year":"2024","unstructured":"Kim AY, Al Jerdi S, MacDonald R and Triggle CR. Alzheimer’s disease and its treatment-yesterday, today, and tomorrow. Front Pharmacol 2024; 15: 1399121.","journal-title":"Front Pharmacol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00018-022-04438-4","article-title":"NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice","volume":"79","author":"Companys-Alemany J","year":"2022","unstructured":"Companys-Alemany J, Turcu AL, Schneider M, Müller CE, Vázquez S, Griñán-Ferré C and Pallàs M. NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice. Cell Mol Life Sci 2022; 79: 408.","journal-title":"Cell Mol Life Sci"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","unstructured":"Song X, Jensen MØ, Jogini V, Stein RA, Lee CH, Mchaourab HS, Shaw DE and Gouaux E. Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature 2018; 556: 515-519.","journal-title":"Nature"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer’s disease","volume":"57","author":"Wang","year":"2017","unstructured":"Wang R and Reddy PH. Role of glutamate and NMDA receptors in Alzheimer’s disease. J Alzheimer’s Dis 2017; 57: 1041-1048.","journal-title":"J Alzheimer&#x2019 s Dis"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1021\/acschemneuro.2c00779","article-title":"Novel GluN2B-selective NMDA receptor negative allosteric modulator possesses intrinsic analgesic properties and enhances analgesia of morphine in a rodent tail flick pain model","volume":"14","author":"Harris","year":"2023","unstructured":"Harris LD, Regan MC, Myers SJ, Nocilla KA, Akins NS, Tahirovic YA, Wilson LJ, Dingledine R, Furukawa H, Traynelis SF and Liotta DC. Novel GluN2B-selective NMDA receptor negative allosteric modulator possesses intrinsic analgesic properties and enhances analgesia of morphine in a rodent tail flick pain model. ACS Chem Neurosci 2023; 14: 917-935.","journal-title":"ACS Chem Neurosci"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jagp.2019.08.011","article-title":"A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints","volume":"28","author":"Lavretsky","year":"2020","unstructured":"Lavretsky H, Laird KT, Krause-Sorio B, Heimberg BF, Yeargin J, Grzenda A, Wu P, Thana-Udom K, Ercoli LM and Siddarth P. A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints. Am J Geriatr Psychiatry 2020; 28: 178-190.","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/hmg\/ddab091","article-title":"Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer’s disease","volume":"30","author":"Reddy","year":"2021","unstructured":"Reddy AP, Sawant N, Morton H, Kshirsagar S, Bunquin LE, Yin X and Reddy PH. Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer’s disease. Hum Mol Genet 2021; 30: 789-810.","journal-title":"Hum Mol Genet"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Koychev I, Adler AI, Edison P, Tom B, Milton JE, Butchart J, Hampshire A, Marshall C, Coulthard E, Zetterberg H, Hellyer P, Cormack F, Underwood BR, Mummery CJ and Holman RR. Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults. BMJ Open 2024; 14: e081401.","DOI":"10.1136\/bmjopen-2023-081401"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1210\/jc.2009-2054","article-title":"Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men","volume":"95","author":"RD","year":"2010","unstructured":"Carr RD, Larsen MO, Jelic K, Lindgren O, Vikman J, Holst JJ, Deacon CF and Ahrén B. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin Endocrinol Metab 2010; 95: 872-878.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12944-023-01985-y","article-title":"Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus","volume":"22","author":"Meng","year":"2023","unstructured":"Meng J, Yan R, Zhang C, Bai X, Yang X, Yang Y, Feng T and Liu X. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus. Lipids Health Dis 2023; 22: 219.","journal-title":"Lipids Health Dis"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"110681","DOI":"10.1016\/j.ijfoodmicro.2024.110681","article-title":"A consortium of different Saccharomyces species enhances the content of bioactive tryptophan-derived compounds in wine fermentations","volume":"416","author":"Planells-C&#xE1","year":"2024","unstructured":"Planells-Cárcel A, Kazakova J, Pérez C, Gonzalez-Ramirez M, Garcia-Parrilla MC and Guillamón JM. A consortium of different Saccharomyces species enhances the content of bioactive tryptophan-derived compounds in wine fermentations. Int J Food Microbiol 2024; 416: 110681.","journal-title":"Int J Food Microbiol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"9968","DOI":"10.3390\/ijms23179968","article-title":"The role of tryptophan metabolites in neuropsychiatric disorders","volume":"23","author":"Davidson","year":"2022","unstructured":"Davidson M, Rashidi N, Nurgali K and Apostolopoulos V. The role of tryptophan metabolites in neuropsychiatric disorders. Int J Mol Sci 2022; 23: 9968.","journal-title":"Int J Mol Sci"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/nu12103183","article-title":"Tryptophan intake and metabolism in older adults with mood disorders","volume":"12","author":"Chojnacki","year":"2020","unstructured":"Chojnacki C, Popławski T, Chojnacki J, Fila M, Konrad P and Blasiak J. Tryptophan intake and metabolism in older adults with mood disorders. Nutrients 2020; 12: 3183.","journal-title":"Nutrients"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.schres.2013.07.009","article-title":"The global cognitive impairment in schizophrenia: consistent over decades and around the world","volume":"150","author":"Schaefer","year":"2013","unstructured":"Schaefer J, Giangrande E, Weinberger DR and Dickinson D. The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res 2013; 150: 42-50.","journal-title":"Schizophr Res"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.pbb.2011.04.013","article-title":"Glutamate receptors in preclinical research on Alzheimer’s disease: update on recent advances","volume":"100","author":"NW","year":"2012","unstructured":"Hu NW, Ondrejcak T and Rowan MJ. Glutamate receptors in preclinical research on Alzheimer’s disease: update on recent advances. Pharmacol Biochem Behav 2012; 100: 855-862.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.pbb.2011.03.023","article-title":"Glutamate signaling in the pathophysiology and therapy of schizophrenia","volume":"100","author":"CH","year":"2012","unstructured":"Lin CH, Lane HY and Tsai GE. Glutamate signaling in the pathophysiology and therapy of schizophrenia. Pharmacol Biochem Behav 2012; 100: 665-677.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41586-024-07419-8","article-title":"GLP-1 directed NMDA receptor antagonism for obesity treatment","volume":"629","author":"Petersen","year":"2024","unstructured":"Petersen J, Ludwig MQ, Juozaityte V, Ranea-Robles P, Svendsen C, Hwang E, Kristensen AW, Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Sachs L, Moreno-Justicia R, Rohlfs R, Ford JC, Douros JD, Finan B, Portillo B, Grose K, Petersen JE, Trauelsen M, Feuchtinger A, DiMarchi RD, Schwartz TW, Deshmukh AS, Thomsen MB, Kohlmeier KA, Williams KW, Pers TH, Frølund B, Strømgaard K, Klein AB and Clemmensen C. GLP-1 directed NMDA receptor antagonism for obesity treatment. Nature 2024; 629: 1133-1141.","journal-title":"Nature"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molmet.2018.03.004","article-title":"Enterochromaffin 5-HT cells - a major target for GLP-1 and gut microbial metabolites","volume":"11","author":"Lund","year":"2018","unstructured":"Lund ML, Egerod KL, Engelstoft MS, Dmytriyeva O, Theodorsson E, Patel BA and Schwartz TW. Enterochromaffin 5-HT cells - a major target for GLP-1 and gut microbial metabolites. Mol Metab 2018; 11: 70-83.","journal-title":"Mol Metab"}],"container-title":["International Journal of Physiology, Pathophysiology and Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ijppp\/16\/5\/ijppp0159588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:04Z","timestamp":1766023084000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijppp\/16\/5\/ijppp0159588.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":128,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/mtwv3745","relation":{},"ISSN":["1944-8171"],"issn-type":[{"value":"1944-8171","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}